- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05331001
Quality of Care in Centers Providing Extracorporeal Membrane Oxygenation
April 15, 2022 updated by: Tharusan Thevathasan, Charite University, Berlin, Germany
Cardiac arrest centers are specialized in treating critically ill patients with severe cardiovascular diseases, such as cardiac arrest, cardiogenic shock or acute myocardial infarction.
Diagnostic and therapeutic measures, such as the use of devices for extracorporeal life support, require highly specialized training and skills.
Apart from extensive medical expertise, physicians and nurses may be exposed to exceptional levels of occupational stressors.
Therefore, excellent medical, psychological and inter-personal training of the medical staff is essential to improve patient outcomes.
Assessment of quality of care is important to provide continuous improvement in patient care and team performance.
To the best of our knowledge, there is no study which examined the quality of care in cardiac arrest centers across key dimensions of quality of care.
Therefore, we aim to assess a bundle of key dimensions, that is psychological strain (P), resource utilization (R), interaction (I) between doctoral and nursing staff, costs of care (C) and education (E) programs for staff (PRICE scheme).
A cross-sectional study will be conducted with doctors and nurses, using a digital quesitonnaire that will cover the five dimensions of the PRICE scheme.
Study Overview
Status
Not yet recruiting
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tharusan Thevathasan, MD
- Phone Number: +4915774407864
- Email: tharusan.thevathasan@charite.de
Study Contact Backup
- Name: Carsten Skurk, MD
- Phone Number: +4930450513702
- Email: carsten.skurk@charite.de
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Permament adult staff which is employed in a cardiac arrest center that provides therapy with extracorporeal membrane oxygenation (ECMO).
Medical doctors and nurses are included.
Description
Inclusion Criteria:
- Adult medical doctors or nurses
- Permament staff in the cardiac arrest center
- Cardiac arrest center that provides therapy with extracorporeal membrane oxygenation (ECMO)
Exclusion Criteria:
- No permanent employment in a cardiac arrest center
- Non-adult staff
- Not a medical doctor or nurse
- Cardiac arrest center that does not provide therapy with ECMO
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Medical doctors
Medical doctors who are employed as permanent staff in a cardiac arrest center which provides extracorporeal membrane oxygenation.
|
|
Nurses
Nurses who are employed as permanent staff in a cardiac arrest center which provides extracorporeal membrane oxygenation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological strain (P)
Time Frame: During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
The psychologial strain of permanent staff in the cardiac arrest center will be assessed based on a standardized questionnaire.
|
During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ressource utilization (R)
Time Frame: During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
The availability of material and non-material ressources and the extent of ressource utilization in the cardiac arrest center will be assessed based on a standardized questionnaire.
|
During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
|
Interaction (I)
Time Frame: During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
The quality of inter-professional interactions between medical doctors and nurses in the cardiac arrest center will be assessed based on a standardized questionnaire.
|
During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
|
Costs (C) of care
Time Frame: During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
The costs of care in the cardiac arrest center will be assessed based on a standardized questionnaire.
|
During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
|
Education (E) programs
Time Frame: During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
The availability and quality of education programs in the cardiac arrest center will be assessed based on a standardized questionnaire.
|
During one week all permanent staff of a cardiac arrest center will be asked to fill out the standardized questionnaire.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tharusan Thevathasan, MD, Charite University
- Study Director: Carsten Skurk, MD, Charite University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2022
Primary Completion (Anticipated)
December 30, 2022
Study Completion (Anticipated)
March 30, 2023
Study Registration Dates
First Submitted
April 10, 2022
First Submitted That Met QC Criteria
April 10, 2022
First Posted (Actual)
April 15, 2022
Study Record Updates
Last Update Posted (Actual)
April 18, 2022
Last Update Submitted That Met QC Criteria
April 15, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ECMO Quality of Care
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Beijing Northland Biotech. Co., Ltd.Not yet recruitingAcute Myocardial Infarction (AMI) | Acute Myocardial Infarction of Anterior Wall | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction With ST Segment Elevation | Acute Myocardial Infarction of Left VentricleChina
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SAWithdrawn
-
Samsung Medical CenterThe Korean Society of CardiologyNot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationCompletedST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionUnited States, Spain, Netherlands, Canada, Australia, Serbia, Egypt, Switzerland, Hungary, United Kingdom, France, Czechia, Nepal, North Macedonia
-
Harbin Medical UniversityNot yet recruitingNon-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)Acute Myocardial Infarction (AMI) | ST-Segment Elevation Myocardial Infarction(STEMI) | Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)China
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom